Citations

Showing 10 of 108104 citations.

The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution
Zhao, Li , Lu, Meng , Nie, Xiaomin , Abudukerimu, Buatikamu, Zhang, Kun , Ning, Zhiyuan, Chen, Yi , Cheng, Jing , Xia, Fangzhen , Wang, Ningjian , Jensen, Michael D. , Lu, Yingli , Zhu, Chunfang , Chen, Chi

Mayo Clinic

Journal of Endocrinology | December 18, 2018 | Volume: 240 | Issue: 2 | Pages: 271-286

10.1530/joe-18-0374 | PMID 30530905 Get It

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are an ideal therapy for type 2 diabetes and, as of recently, for obesity. In contrast to visceral fat, subcutaneous fat appears to be protective against metabolic diseases. Here, we aimed to explore whether liraglutide, a GLP-1RA, could redistribute body fat via regulating lipid metabolism in different fat depots. After being fed a high-fat diet for 8 weeks, 50 male Wistar and Goto-Kakizaki rats were randomly divided into a normal control group, a diabetic control group, low- and high-dose liraglutide-treated groups and a diet-control group. Different doses of liraglutide (400 μg/kg/day or 1200 μg/kg/day) or an equal volume of normal saline were administered to the rats subcutaneously once a day for 12 weeks. Body composition and body fat deposition were measured by dual-energy X-ray absorptiometry and MRI. Isotope tracers were infused to explore lipid metabolism in different fat depots. Quantitative real-time PCR and Western blot analyses were conducted to evaluate the expression of adipose-related genes. The results showed that liraglutide decreased visceral fat and relatively increased subcutaneous fat. Lipogenesis was reduced in visceral white adipose tissue (WAT) but was elevated in subcutaneous WAT. Lipolysis was also attenuated, and fatty acid oxidation was enhanced. The mRNA expression levels of adipose-related genes in different tissues displayed similar trends after liraglutide treatment. In addition, the expression of browning-related genes was upregulated in subcutaneous WAT. Taken together, the results suggested that liraglutide potentially redistributes body fat and promotes browning remodeling in subcutaneous WAT to improve metabolic disorders.
Quiescent-Interval Single-Shot Magnetic Resonance Angiography
Saini, Aman , Wallace, Alex, Albadawi, Hassan , Naidu, Sailendra , Alzubaidi, Sadeer , Knuttinen, M. Grace , Panda, Anshuman , Öklü, Rahmi , Oklu, Rahmi

Mayo Clinic

Diagnostics | December 18, 2018 | Volume: 8 | Issue: 4 | Pages: 84

10.3390/diagnostics8040084 | PMID 30567304 Get It

Lower extremity peripheral arterial disease (PAD) is a chronic, debilitating disease with a significant global burden. A number of diagnostic imaging techniques exist, including computed tomography angiography (CTA) and contrast-enhanced magnetic resonance angiography (CEMRA), to aid in PAD diagnosis and subsequent treatment planning. Due to concerns of renal toxicity or nephrogenic systemic fibrosis (NSF) for iodinated and gadolinium-based contrasts, respectively, a number of non-enhanced MRA (NEMRA) protocols are being increasingly used in PAD diagnosis. These techniques, including time of flight and phase contrast MRA, have previously demonstrated poor image quality, long acquisition times, and/or susceptibility to artifacts when compared to existing contrast-enhanced techniques. In recent years, Quiescent-Interval Single-Shot (QISS) MRA has been developed to overcome these limitations in NEMRA methods, with promising results. Here, we review the various screening and diagnostic tests currently used for PAD. The various NEMRA protocols are discussed, followed by a comprehensive review of the literature on QISS MRA to date. A particular emphasis is placed on QISS MRA feasibility studies and studies comparing the diagnostic accuracy and image quality of QISS MRA versus other diagnostic imaging techniques in PAD.
Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles from Large Volumes of Fluid
Busatto, Sara , Vilanilam, George K. , Ticer, Taylor , Lin, Wen‐Lang, Shapiro, Shane A. , Bergese, Paolo , Wolfram, Joy , Vilanilam, George , Shapiro, Shane , Bergese, Paolo , Wolfram, Joy , Dickson, Dennis W.

Mayo Clinic

Cells | December 18, 2018 | Volume: 7 | Issue: 12 | Pages: 273

10.3390/cells7120273 | PMID 30558352 Get It

Concentration of extracellular vesicles (EVs) from biological fluids in a scalable and reproducible manner represents a major challenge. This study reports the use of tangential flow filtration (TFF) for the highly efficient isolation of EVs from large volumes of samples. When compared to ultracentrifugation (UC), which is the most widely used method to concentrate EVs, TFF is a more efficient, scalable, and gentler method. Comparative assessment of TFF and UC of conditioned cell culture media revealed that the former concentrates EVs of comparable physicochemical characteristics, but with higher yield, less single macromolecules and aggregates (<15 nm in size), and improved batch-to-batch consistency in half the processing time (1 h). The TFF protocol was then successfully implemented on fluids derived from patient lipoaspirate. EVs from adipose tissue are of high clinical relevance, as they are expected to mirror the regenerative properties of the parent cells.
Pulmonary Artery Systolic Pressure Measured Intraoperatively by Right Heart Catheterization Is a Predictor of Kidney Transplant Recipient Survival
Doumit, Elias, Makdisi, George, Mhaskar, Rahul , Miladinović, Branko, Wadei, Hani M. , Rumbak, Mark J., Aslam, Sadaf , Wadei, Hani, Wadei, Hani M , Jarmi, Tambi

Mayo Clinic

Annals of Transplantation | December 18, 2018 | Volume: 23 | Issue: No issue available | Pages: 867-873

10.12659/aot.911176 | PMID 30559336 Get It

Acute Pancreatitis
Twedell, Diane, Pfrimmer, Megan, Twedell, Diane, Pfrimmer, Megan

Mayo Clinic

The Journal of Continuing Education in Nursing | December 17, 2018 | Volume: 39 | Issue: 8 | Pages: 341-342

10.3928/00220124-20080801-01 | PMID 18714608 Get It

This column discusses the pathophysiology, signs and symptoms, complications, treatments, and care of acute pancreatitis. J Contin Educ Nurs 2008;39(8):341–342.
Assessing the Bleeding Patient: Factors Affecting Hemostasis and Common Coagulation Studies
Liedl, Chad P., Friedrich, Tammy

Mayo Clinic

The Journal of Continuing Education in Nursing | December 17, 2018 | Volume: 38 | Issue: 6 | Pages: 247-248

10.3928/00220124-20071101-01 | PMID 18050979 Get It

This column discusses the factors affecting hemostasis and the common coagulation studies used to assess patients with bleeding disorders.
Heart Failure
Foy, Denise

Mayo Clinic

The Journal of Continuing Education in Nursing | December 17, 2018 | Volume: 38 | Issue: 5 | Pages: 198-199

10.3928/00220124-20070901-03 | PMID 17907662 Get It

Heart failure is the most common reason for hospital admission in the United States. All nurses, regardless of their specialty, should be familiar with this clinical syndrome. This column describes the pathophysiology and treatment of heart failure.
Emphysema and Lung Volume Reduction Surgery
Caflisch, Annette J., Caflisch, Annette J

Mayo Clinic

The Journal of Continuing Education in Nursing | December 17, 2018 | Volume: 38 | Issue: 4 | Pages: 150-151

10.3928/00220124-20070701-03 | PMID 17708112 Get It

Patients with emphysema suffer from a poor quality of life. Treatment options vary, but surgical treatment may have the greatest positive effect on this patient population.
Body Contouring Following Major Weight Loss
McGohan, LaDonna D., Twedell, Diane M.

Mayo Clinic

The Journal of Continuing Education in Nursing | December 17, 2018 | Volume: 38 | Issue: 3 | Pages: 103-104

10.3928/00220124-20070501-01 | PMID 17542167 Get It

Body contouring is a highly specialized and quickly growing field of plastic surgery. This article describes some of the types of body contouring surgery individuals who have experienced massive weight loss may seek.
Diabetes Mellitus Update
Seelandt, Katherine K.

Mayo Clinic

The Journal of Continuing Education in Nursing | December 17, 2018 | Volume: 38 | Issue: 2 | Pages: 54-55

10.3928/00220124-20070301-07 | PMID 17402375 Get It